LLY

811.14

+0.38%↑

JNJ

156.56

+0.93%↑

ABBV

192.22

+0.51%↑

NVO

81.08

+3.14%↑

UNH

318.1

+2.45%↑

LLY

811.14

+0.38%↑

JNJ

156.56

+0.93%↑

ABBV

192.22

+0.51%↑

NVO

81.08

+3.14%↑

UNH

318.1

+2.45%↑

LLY

811.14

+0.38%↑

JNJ

156.56

+0.93%↑

ABBV

192.22

+0.51%↑

NVO

81.08

+3.14%↑

UNH

318.1

+2.45%↑

LLY

811.14

+0.38%↑

JNJ

156.56

+0.93%↑

ABBV

192.22

+0.51%↑

NVO

81.08

+3.14%↑

UNH

318.1

+2.45%↑

LLY

811.14

+0.38%↑

JNJ

156.56

+0.93%↑

ABBV

192.22

+0.51%↑

NVO

81.08

+3.14%↑

UNH

318.1

+2.45%↑

Search

CorMedix Inc

Closed

SectorHealthcare

14.8 0.68

Overview

Share price change

24h

Current

Min

13.79

Max

14.89

Key metrics

By Trading Economics

Income

7.2M

21M

Sales

7.9M

39M

P/E

Sector Avg

57.4

51.748

EPS

0.299

Profit margin

52.822

Employees

64

EBITDA

7.2M

21M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+21.11% upside

Dividends

By Dow Jones

Next Earnings

13 Aug 2025

Market Stats

By TradingEconomics

Market Cap

337M

973M

Previous open

14.12

Previous close

14.8

News Sentiment

By Acuity

50%

50%

172 / 380 Healthcare

Technical Score

By Trading Central

Confidence

Strong Bullish Evidence

CorMedix Inc Chart

Past performance is not a reliable indicator of future results.

Related News

12 Jun 2025, 20:41 UTC

Earnings

Adobe Raises Outlook After 2Q Sales Beat

12 Jun 2025, 23:50 UTC

Earnings

Adobe Keeps Pivoting as AI Transforms Customer Needs -- Update

12 Jun 2025, 23:50 UTC

Earnings

Adobe Customer Demand Shifting Toward Idea Generation, CFO Says

12 Jun 2025, 23:50 UTC

Earnings

Adobe FireFly Products Drove Revenue Beat in 2Q, CFO Says

12 Jun 2025, 23:48 UTC

Market Talk

Gold Steady Amid Geopolitical Risks -- Market Talk

12 Jun 2025, 23:45 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

12 Jun 2025, 23:45 UTC

Market Talk

Nikkei May Trade Rangebound Amid Tariff Uncertainty -- Market Talk

12 Jun 2025, 21:26 UTC

Earnings

Friedman Industries 4Q Sales $129.2M >FRD

12 Jun 2025, 21:25 UTC

Earnings

Friedman Industries 4Q EPS 76c >FRD

12 Jun 2025, 21:11 UTC

Earnings

Adobe Beat Estimates and Raises Revenue Guidance -- Barrons.com

12 Jun 2025, 20:50 UTC

Market Talk
Earnings

Tech, Media & Telecom Roundup: Market Talk

12 Jun 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

12 Jun 2025, 20:31 UTC

Earnings

Adobe Beat Estimates and Raises Revenue Guidance -- Barrons.com

12 Jun 2025, 20:30 UTC

Earnings
Acquisitions, Mergers, Takeovers

Chime IPO: Stock Soars in Nasdaq Debut, Valuing It at Nearly $14 Billion -- Barrons.com

12 Jun 2025, 20:15 UTC

Earnings

Adobe Sees FY25 Rev $23.5B-$23.6B >ADBE

12 Jun 2025, 20:15 UTC

Earnings

Adobe Sees 3Q Rev $5.88B-$5.93B >ADBE

12 Jun 2025, 20:14 UTC

Earnings

Adobe Stock Pops as Earnings Beat Estimates -- Barrons.com

12 Jun 2025, 20:07 UTC

Earnings

Adobe Raises FY25 Rev and EPS Targets

12 Jun 2025, 20:05 UTC

Earnings

Adobe Sees FY Adj EPS $20.50-Adj EPS $20.70 >ADBE

12 Jun 2025, 20:05 UTC

Earnings

Adobe 2Q Digital Experience Revenue $1.46B >ADBE

12 Jun 2025, 20:05 UTC

Earnings

Adobe 2Q Digital Media Revenue $4.35B >ADBE

12 Jun 2025, 20:05 UTC

Earnings

Adobe Sees 3Q EPS $4.00-EPS $4.05 >ADBE

12 Jun 2025, 20:05 UTC

Earnings

Adobe 2Q Net $1.69B >ADBE

12 Jun 2025, 20:05 UTC

Earnings

Adobe 2Q EPS $3.94 >ADBE

12 Jun 2025, 20:05 UTC

Earnings

Adobe 2Q Digital Experience Revenue Up 10% >ADBE

12 Jun 2025, 20:05 UTC

Earnings

Adobe 2Q Rev $5.87B >ADBE

12 Jun 2025, 20:05 UTC

Earnings

Adobe Sees 3Q Adj EPS $5.15-Adj EPS $5.20 >ADBE

12 Jun 2025, 20:05 UTC

Earnings

Adobe Sees FY EPS $16.30-EPS $16.50 >ADBE

12 Jun 2025, 20:05 UTC

Earnings

Adobe 2Q Digital Media Revenue Up 11% >ADBE

12 Jun 2025, 20:05 UTC

Earnings

Adobe 2Q Adj EPS $5.06 >ADBE

Peer Comparison

Price change

CorMedix Inc Forecast

Price Target

By TipRanks

21.11% upside

12 Months Forecast

Average 17.67 USD  21.11%

High 20 USD

Low 13 USD

Based on 6 Wall Street analysts offering 12 month price targets forCorMedix Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

6 ratings

6

Buy

0

Hold

0

Sell

Technical Score

By Trading Central

9.2 / N/ASupport & Resistance

Short Term

Strong Bullish Evidence

Intermediate Term

Weak Bullish Evidence

Long Term

Strong Bullish Evidence

Sentiment

By Acuity

172 / 380 Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About CorMedix Inc

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.